Lucira Health, Inc. financial data

Industry
In Vitro & In Vivo Diagnostic Substances
Location
1315 63 Rd Street, Emeryville, CA
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2022 - Nov 14, 2022

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 310 % -63.5%
Quick Ratio 115 % -6.62%
Debt-to-equity 60 % +216%
Return On Equity -89.6 % -74.7%
Return On Assets -56 % -52.7%
Operating Margin -66.9 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 40.6M shares +3.5%
Common Stock, Shares, Outstanding 40.4M shares +3.71%
Common Stock, Value, Issued 40K USD +2.56%
Weighted Average Number of Shares Outstanding, Basic 40.2M shares +4.01%
Weighted Average Number of Shares Outstanding, Diluted 40.2M shares +4.01%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 34.4M USD
Revenue from Contract with Customer, Excluding Assessed Tax 212M USD +130%
Research and Development Expense 41.2M USD +4.92%
Operating Income (Loss) -142M USD -103%
Nonoperating Income (Expense) -1.37M USD +69.4%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -143M USD -361%
Income Tax Expense (Benefit) 33K USD
Net Income (Loss) Attributable to Parent -143M USD -93.1%
Earnings Per Share, Basic -3.15 USD/shares -344%
Earnings Per Share, Diluted -3.15 USD/shares -344%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 39.8M USD -66.1%
Accounts Receivable, after Allowance for Credit Loss, Current 14.4M USD +20.9%
Inventory, Net 55.6M USD +29.5%
Other Assets, Current 3.35M USD -66.8%
Assets, Current 120M USD -37.5%
Property, Plant and Equipment, Net 48.3M USD +79.2%
Operating Lease, Right-of-Use Asset 17.7M USD +549%
Other Assets, Noncurrent 772K USD +215%
Assets 189M USD -15.1%
Accounts Payable, Current 25.2M USD +141%
Accrued Liabilities, Current 55M USD +262%
Liabilities, Current 82.5M USD +201%
Operating Lease, Liability, Noncurrent 16.4M USD +1100%
Liabilities 128M USD +345%
Retained Earnings (Accumulated Deficit) -264M USD -119%
Stockholders' Equity Attributable to Parent 60.9M USD -68.6%
Liabilities and Equity 189M USD -15.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -5.3M USD +76.9%
Net Cash Provided by (Used in) Financing Activities 29.2M USD -81.8%
Net Cash Provided by (Used in) Investing Activities -8.13M USD -46.5%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 40.4M shares +3.71%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 15.8M USD -88%
Interest Paid, Excluding Capitalized Interest, Operating Activities 183K USD
Operating Lease, Liability 18.7M USD +570%
Payments to Acquire Property, Plant, and Equipment 8.13M USD +46.5%
Lessee, Operating Lease, Liability, to be Paid 29M USD +866%
Property, Plant and Equipment, Gross 58.1M USD +92%
Operating Lease, Liability, Current 2.32M USD +62.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.92M USD +181%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.73M USD +93.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure +27%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 10.3M USD +4759%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.9M USD +1872%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 1.1M USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.99M USD
Operating Lease, Payments 500K USD +400%
Additional Paid in Capital 325M USD +3.23%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 6.46M USD +30.8%
Share-based Payment Arrangement, Expense 7.58M USD +13.1%
Interest Expense 949K USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%